5.35
0.14 (2.69%)
0.14 (2.69%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Catalyst Pharmaceuticals Inc | CPRX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Low Price | High Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 0.01 | 0.19% | 5.21 | 5.00 | 5.27 | 5.20 | 5.20 | 19:34:48 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 5.23 | 5.35 | 0.12 | 2.24% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 15,610 | 2,256,820 | $ 5.15 | $ 11,630,612 | 1,734,594 | 2.235 - 7.67 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:41:51 | 49 | $ 5.35 | USD |
Catalyst Pharmaceuticals Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 536.88M | 103.05M | $ -34.00M | -0.34 | 65.00 | 93.86M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Catalyst Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CPRX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 4.89 | 5.28 | 4.76 | 5.08 | 2,032,117 | 0.32 | 6.54% |
| 1 Month | 4.20 | 5.28 | 3.84 | 4.56 | 1,578,342 | 1.01 | 24.05% |
| 3 Months | 4.64 | 5.28 | 3.64 | 4.30 | 2,200,264 | 0.57 | 12.28% |
| 6 Months | 6.20 | 7.67 | 3.64 | 4.92 | 2,310,592 | -0.99 | -15.97% |
| 1 Year | 2.80 | 7.67 | 2.235 | 4.57 | 2,227,435 | 2.41 | 86.07% |
| 3 Years | 1.16 | 7.67 | 1.08 | 3.73 | 1,421,524 | 4.05 | 349.14% |
| 5 Years | 3.37 | 7.67 | 0.51 | 3.31 | 1,172,275 | 1.84 | 54.6% |
Catalyst Pharmaceuticals Description
| Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing innovative therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with lambert-eaton myasthenic syndrome. |
